Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer

Colorectal cancer (CRC) is one of the most common cancers, with a high mortality rate, and is a major burden on human health worldwide. Gut microbiota regulate human immunity and metabolism through producing numerous metabolites, which act as signaling molecules and substrates for metabolic reactions in various biological processes. The importance of host-gut microbiota interactions in immunometabolic mechanisms in CRC is increasingly recognized, and interest in modulating the microbiota to improve patient’s response to therapy has been raising. However, the specific mechanisms by which gut microbiota interact with immunotherapy and radiotherapy remain incongruent. Here we review recent advances and discuss the feasibility of gut microbiota as a regulatory target to enhance the immunogenicity of CRC, improve the radiosensitivity of colorectal tumor cells and ameliorate complications such as radiotoxicity. Currently, great breakthroughs in the treatment of non-small cell lung cancer and others have been achieved by radioimmunotherapy, but radioimmunotherapy alone has not been effective in CRC patients. By summarizing the recent preclinical and clinical evidence and considering regulatory roles played by microflora in the gut, such as anti-tumor immunity, we discuss the potential of targeting gut microbiota to enhance the efficacy of radioimmunotherapy in CRC and expect this review can provide references and fresh ideas for the clinical application of this novel strategy.

[1]  Han Shuwen,et al.  Using whole-genome sequencing (WGS) to plot colorectal cancer-related gut microbiota in a population with varied geography , 2022, Gut Pathogens.

[2]  R. Palmqvist,et al.  Tumour Colonisation of Parvimonas micra Is Associated with Decreased Survival in Colorectal Cancer Patients , 2022, Cancers.

[3]  Kui Luo,et al.  Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. , 2022, Chemical Society reviews.

[4]  Ruitao Cha,et al.  Nitroreductase-instructed supramolecular assemblies for microbiome regulation to enhance colorectal cancer treatments , 2022, Science advances.

[5]  J. Crawford,et al.  Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites , 2022, Science.

[6]  Y. Hamamoto,et al.  CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule , 2022, BMC Cancer.

[7]  Jie Ma,et al.  Predictive value of tumor-infiltrating lymphocytes detected by flow cytometry in colorectal cancer. , 2022, International immunopharmacology.

[8]  Guolian Zhu,et al.  Efficacy and safety of anti-PD-1/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis , 2022, BMC Gastroenterology.

[9]  Jiarui Li,et al.  Immunotherapies catering to the unmet medical need of cold colorectal cancer , 2022, Frontiers in Immunology.

[10]  Y. Zhang,et al.  Mechanism and strategies of immunotherapy resistance in colorectal cancer , 2022, Frontiers in Immunology.

[11]  Lei Zhang,et al.  Inhibition of UBA6 by inosine augments tumour immunogenicity and responses , 2022, Nature Communications.

[12]  Jianzhuang Ren,et al.  Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment , 2022, Frontiers in Immunology.

[13]  F. Baltazar,et al.  Colon microbiota modulation by dairy-derived diet: new strategy for prevention and treatment of colorectal cancer. , 2022, Food & function.

[14]  L. D. Di Stasi,et al.  Gut microbiota, inflammatory bowel disease and colorectal cancer , 2022, World journal of gastroenterology.

[15]  Helen Y Wang,et al.  Interaction between microbiota and immunity and its implication in colorectal cancer , 2022, Frontiers in Immunology.

[16]  S. Wong,et al.  Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients , 2022, Oncogene.

[17]  Xuan Yi,et al.  Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy. , 2022, ACS nano.

[18]  Fenghua Wang,et al.  Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study , 2022, Journal of Cancer.

[19]  Chunyan Wu,et al.  Integrated analysis of colorectal cancer reveals cross-cohort gut microbial signatures and associated serum metabolites. , 2022, Gastroenterology.

[20]  C. Guda,et al.  Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer , 2022, Microbiology spectrum.

[21]  Harpreet Kaur,et al.  Probiotics and gut microbiota: mechanistic insights into gut immune homeostasis through TLR pathway regulation. , 2022, Food & function.

[22]  Qing Li,et al.  Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis , 2022, Frontiers in Physiology.

[23]  Kuerbannaimu Kaheman,et al.  Lactobacillus acidophilus and HKL Suspension Alleviates Ulcerative Colitis in Rats by Regulating Gut Microbiota, Suppressing TLR9, and Promoting Metabolism , 2022, Frontiers in Pharmacology.

[24]  C. Cheze-le Rest,et al.  FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer. , 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[25]  Hongzhong Li,et al.  Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies , 2022, Journal of Hematology & Oncology.

[26]  Teng Liu,et al.  131I-αPD-L1 immobilized by bacterial cellulose for enhanced radio-immunotherapy of cancer. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Hui Li,et al.  Gut microbiota modulation: a tool for the management of colorectal cancer , 2022, Journal of Translational Medicine.

[28]  Helen Y Wang,et al.  Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity , 2022, Frontiers in Immunology.

[29]  V. Notario,et al.  The Interplay among Radiation Therapy, Antibiotics and the Microbiota: Impact on Cancer Treatment Outcomes , 2022, Antibiotics.

[30]  S. Wong,et al.  Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers , 2022, Microbiome.

[31]  C. Heeschen,et al.  Multi-kingdom microbiota analyses identify bacterial–fungal interactions and biomarkers of colorectal cancer across cohorts , 2022, Nature Microbiology.

[32]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[33]  Jared C Malke,et al.  Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response , 2021, Science.

[34]  A. Korman,et al.  The foundations of immune checkpoint blockade and the ipilimumab approval decennial , 2021, Nature Reviews Drug Discovery.

[35]  Jun Yu,et al.  Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis , 2021, Gut.

[36]  Bangmao Wang,et al.  Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation? , 2021, Cancer letters.

[37]  F. Ris,et al.  Study protocol of a phase II study to evaluate safety and efficacy of neo-adjuvant pembrolizumab and radiotherapy in localized rectal cancer , 2021, BMC Cancer.

[38]  M. Kudo,et al.  Intestinal Microbiota and Gene Expression Reveal Similarity and Dissimilarity Between Immune-Mediated Colitis and Ulcerative Colitis , 2021, Frontiers in Oncology.

[39]  Lingmao Tang,et al.  Dysbiosis of Gut Microbiota Is Associated With the Progression of Radiation-Induced Intestinal Injury and Is Alleviated by Oral Compound Probiotics in Mouse Model , 2021, Frontiers in Cellular and Infection Microbiology.

[40]  R. Rodrigues,et al.  Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment , 2021, Cell.

[41]  Yan Ma,et al.  The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review , 2021, Radiation oncology.

[42]  A. Awasthi,et al.  High-salt diet mediates interplay between NK cells and gut microbiota to induce potent tumor immunity , 2021, Science advances.

[43]  R. Soares,et al.  The Effects of Ionizing Radiation on Gut Microbiota, a Systematic Review , 2021, Nutrients.

[44]  Juliel Espinosa,et al.  Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy , 2021, Science.

[45]  Jie Hong,et al.  Enterotoxigenic Bacteroides fragilis promotes intestinal inflammation and malignancy by inhibiting exosomes-packaged miR-149-3p. , 2021, Gastroenterology.

[46]  Mohamed Mysara,et al.  Irradiation at ultra-high (FLASH) dose rates reduces acute normal tissue toxicity in the mouse gastrointestinal system. , 2021, International journal of radiation oncology, biology, physics.

[47]  Emily Y. Ko,et al.  Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy. , 2021, Cancer cell.

[48]  Ying-bin Liu,et al.  Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression , 2021, Cell reports. Medicine.

[49]  T. Gress,et al.  Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer , 2021, Nature Communications.

[50]  J. Zhang,et al.  A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics , 2021, Clinical and Translational Oncology.

[51]  B. Saeedi,et al.  Lactobacillus rhamnosus GG Orchestrates an Antitumor Immune Response , 2021, Cellular and molecular gastroenterology and hepatology.

[52]  H. Geinitz,et al.  Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): A prospective randomized, open-label, multicenter, phase II clinical trial. , 2021 .

[53]  Zhide Guo,et al.  Combined PD-L1–targeted radionuclide therapy with immunotherapy in two models of colorectal cancer , 2021 .

[54]  P. Rosenstiel,et al.  Colibactin-Producing Escherichia coli Induce the Formation of Invasive Carcinomas in a Chronic Inflammation-Associated Mouse Model , 2021, Cancers.

[55]  S. Yooseph,et al.  Bacterial community structure alterations within the colorectal cancer gut microbiome , 2021, BMC microbiology.

[56]  R. Weichselbaum,et al.  Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade , 2021, Gut.

[57]  A. Jazaeri,et al.  A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers , 2021, PloS one.

[58]  Ricky A. Sharma,et al.  FLASH Proton Pencil Beam Scanning Irradiation Minimizes Radiation-Induced Leg Contracture and Skin Toxicity in Mice , 2021, Cancers.

[59]  Mia Yang Ang,et al.  Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer , 2021, Scientific Reports.

[60]  J. Gilbert,et al.  Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation , 2021, The Journal of experimental medicine.

[61]  J. Yue,et al.  Radiotherapy and the gut microbiome: facts and fiction , 2021, Radiation oncology.

[62]  P. Gourraud,et al.  The Caspase-1/IL-18 Axis of the Inflammasome in Tumor Cells: A Modulator of the Th1/Tc1 Response of Tumor-Infiltrating T Lymphocytes in Colorectal Cancer , 2021, Cancers.

[63]  N. Ajami,et al.  Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation , 2020, Communications Biology.

[64]  N. Ajami,et al.  Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients , 2020, Science.

[65]  Lijun Shen,et al.  The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study , 2020, Frontiers in Cellular and Infection Microbiology.

[66]  I. Weissman,et al.  Effects of ultra-high dose rate FLASH irradiation on the tumor microenvironment in Lewis lung carcinoma: role of myosin light chain. , 2020, International journal of radiation oncology, biology, physics.

[67]  M. Hitt,et al.  The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer , 2020, International journal of molecular sciences.

[68]  J. Shia The diversity of tumours with microsatellite instability: molecular mechanisms and impact upon microsatellite instability testing and mismatch repair protein immunohistochemistry , 2020, Histopathology.

[69]  D. McSkimming,et al.  Gut Microbiota and Immune System Interactions , 2020, Microorganisms.

[70]  D. Tamandl,et al.  P08.04 Neoadjuvant chemoradiotherapy with sequential ipilimumab and nivolumab in rectal cancer (CHINOREC): a prospective randomized, open-label, multicenter, phase II clinical trial , 2020 .

[71]  Xinrui Zhao,et al.  Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade , 2020, Cancers.

[72]  Xingxiang He,et al.  Multi-donor multi-course faecal microbiota transplantation relieves the symptoms of chronic hemorrhagic radiation proctitis , 2020, Medicine.

[73]  Jun Yu,et al.  Streptococcus thermophilus inhibits colorectal tumorigenesis through secreting β-galactosidase. , 2020, Gastroenterology.

[74]  R. Weichselbaum,et al.  Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation Therapy. , 2020, International journal of radiation oncology, biology, physics.

[75]  David T. W. Tzeng,et al.  The Gut Microbiome Is Associated with Clinical Response to Anti–PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer , 2020, Cancer Immunology Research.

[76]  Kai Yang,et al.  Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer , 2020, Science Advances.

[77]  K. Sun,et al.  Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors , 2020, Frontiers in Cell and Developmental Biology.

[78]  Zhenwei Yang,et al.  The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis , 2020, International Journal of Colorectal Disease.

[79]  Junjie Wang,et al.  Stereotactic Ablative Radiotherapy for Colorectal Cancer Liver Metastasis. , 2020, Seminars in cancer biology.

[80]  S. Górska,et al.  The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review , 2020, Nutrients.

[81]  M. Ashrafizadeh,et al.  Abscopal effect in radioimmunotherapy. , 2020, International immunopharmacology.

[82]  Shasha Liu,et al.  Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients , 2020, Journal of Hematology & Oncology.

[83]  Lijin Zhang,et al.  Radiotherapy Induces Intestinal Barrier Dysfunction by Inhibiting Autophagy , 2020, ACS omega.

[84]  T. Vanden Berghe,et al.  Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer , 2020, Nature Medicine.

[85]  Saijun Fan,et al.  Gut microbiota-derived indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein , 2020, Microbiome.

[86]  N. Oleinick,et al.  Ultra-High Dose Rate Effect on Circulating Immune Cells: A Potential Mechanism for FLASH Effect? , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[87]  Koichi Inoue,et al.  Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors , 2020, JAMA network open.

[88]  E. Choi,et al.  The emerging role of myeloid-derived suppressor cells in radiotherapy , 2020, Radiation oncology journal.

[89]  A. Rogala,et al.  Strategies to Dissect Host-Microbial Immune Interactions That Determine Mucosal Homeostasis vs. Intestinal Inflammation in Gnotobiotic Mice , 2020, Frontiers in Immunology.

[90]  Bota Cui,et al.  Fecal microbiota transplantation: A promising treatment for radiation enteritis? , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[91]  J. O’Sullivan,et al.  Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers , 2020, Nature Reviews Gastroenterology & Hepatology.

[92]  Guoqiang Jiang,et al.  Biostimulating Gut Microbiome with Bilberry Anthocyanin Combo to Enhance Anti-PD-L1 Efficiency against Murine Colon Cancer , 2020, Microorganisms.

[93]  Dongpei Li,et al.  Cancer immunotherapy: Pros, cons and beyond. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[94]  P. Rosenstiel,et al.  Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-producing Escherichia coli in ApcMin/+ Mice. , 2020, Gastroenterology.

[95]  F. Bushman,et al.  Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. , 2019, The Journal of clinical investigation.

[96]  M. Delorenzi,et al.  Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ , 2019, EMBO molecular medicine.

[97]  Jingyan Xie,et al.  Lysates of Lactobacillus acidophilus combined with CTLA-4-blocking antibodies enhance antitumor immunity in a mouse colon cancer model , 2019, Scientific Reports.

[98]  Yu Liu,et al.  Protective Role of Fecal Microbiota Transplantation on Colitis and Colitis-Associated Colon Cancer in Mice Is Associated With Treg Cells , 2019, Front. Microbiol..

[99]  J. Bourhis,et al.  Treatment of a first patient with FLASH-radiotherapy. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[100]  S. Mani,et al.  Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System , 2019, Microorganisms.

[101]  L. Zitvogel,et al.  The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[102]  Koichi Ito,et al.  DETERMINATION OF GUT BACTERIAL METABOLITES IN RADIATION EXPOSED MICE. , 2019, Radiation protection dosimetry.

[103]  Jeong-Seok Nam,et al.  The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance , 2019, Journal of Experimental & Clinical Cancer Research.

[104]  T. Luong,et al.  The Obese Liver Environment Mediates Conversion of NK Cells to a Less Cytotoxic ILC1-Like Phenotype , 2019, Front. Immunol..

[105]  K. Fitzgerald,et al.  DNA sensing by the cGAS–STING pathway in health and disease , 2019, Nature Reviews Genetics.

[106]  Jun Yu,et al.  Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity , 2019, Nature Microbiology.

[107]  G. Reid,et al.  Probiotics and prebiotics in intestinal health and disease: from biology to the clinic , 2019, Nature Reviews Gastroenterology & Hepatology.

[108]  Lisong Shen,et al.  Probiotics Lactobacillus reuteri Abrogates Immune Checkpoint Blockade-Associated Colitis by Inhibiting Group 3 Innate Lymphoid Cells , 2019, Front. Immunol..

[109]  P. Bork,et al.  Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation , 2019, Nature Medicine.

[110]  Xia Wang,et al.  Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy , 2019, Journal of cellular and molecular medicine.

[111]  Paul Theodor Pyl,et al.  Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer , 2019, Nature Medicine.

[112]  A. Giobbie-Hurder,et al.  Analysis of colorectal cancer patients treated on ETCTN 10021: A multicenter randomized trial of combined PD-L1 and CTLA-4 inhibition with targeted low-dose or hypofractionated radiation. , 2019, Journal of Clinical Oncology.

[113]  D. Brenner,et al.  Biological effects in normal cells exposed to FLASH dose rate protons. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[114]  Y. Sakai,et al.  The Role of Tumor-Associated Neutrophils in Colorectal Cancer , 2019, International journal of molecular sciences.

[115]  C. Brennan,et al.  Tumor mutational load predicts survival after immunotherapy across multiple cancer types , 2019, Nature Genetics.

[116]  D. Plichta,et al.  A defined commensal consortium elicits CD8 T cells and anti-cancer immunity , 2019, Nature.

[117]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[118]  R. Muschel,et al.  Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade , 2018, EMBO molecular medicine.

[119]  Leaf Huang,et al.  Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis , 2018, Advanced materials.

[120]  B. Yaremko,et al.  Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[121]  David M. Alvarado,et al.  Lactobacillus rhamnosus GG protects the intestinal epithelium from radiation injury through release of lipoteichoic acid, macrophage activation and the migration of mesenchymal stem cells , 2018, Gut.

[122]  H. Tilg,et al.  The Intestinal Microbiota in Colorectal Cancer. , 2018, Cancer cell.

[123]  M. Ciorba,et al.  Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis , 2018, Current opinion in supportive and palliative care.

[124]  K. Kristiansen,et al.  Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers , 2018, Microbiome.

[125]  Zhenwei Dai,et al.  Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers , 2018, Microbiome.

[126]  Shiyu Song,et al.  The role of bacteria in cancer therapy – enemies in the past, but allies at present , 2018, Infectious Agents and Cancer.

[127]  Dai Fukumura,et al.  Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges , 2018, Nature Reviews Clinical Oncology.

[128]  Laurence Zitvogel,et al.  Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors , 2018, Science.

[129]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[130]  D. Pardoll,et al.  Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. , 2018, Cell host & microbe.

[131]  A. Plastiras,et al.  Waiting Time following Neoadjuvant Chemoradiotherapy for Rectal Cancer: Does It Really Matter , 2017, Gastrointestinal Tumors.

[132]  G. Banna,et al.  Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer , 2017, Front. Pharmacol..

[133]  Y. Kashi,et al.  Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction , 2017, Gut.

[134]  Soumen Roy,et al.  Microbiota: a key orchestrator of cancer therapy , 2017, Nature Reviews Cancer.

[135]  K. Schalper,et al.  Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming. , 2016, Cancer research.

[136]  M. Hettich,et al.  Checkpoint Antibodies but not T Cell-Recruiting Diabodies Effectively Synergize with TIL-Inducing γ-Irradiation. , 2016, Cancer research.

[137]  M. Bernstein,et al.  Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. , 2016, International journal of radiation oncology, biology, physics.

[138]  Jason B. Williams,et al.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.

[139]  H. Ishwaran,et al.  Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer , 2015, Nature.

[140]  R. Weichselbaum,et al.  STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. , 2014, Immunity.

[141]  I. Stratford,et al.  Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade. , 2014, Cancer research.

[142]  S. Demaria,et al.  Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death , 2014, Oncoimmunology.

[143]  R. Weichselbaum,et al.  Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. , 2014, The Journal of clinical investigation.

[144]  C. Pichard,et al.  Interaction of ω-3 polyunsaturated fatty acids with radiation therapy in two different colorectal cancer cell lines. , 2014, Clinical nutrition.

[145]  S. Ferrone,et al.  Abstract 632: Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing , 2014 .

[146]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.

[147]  Jack David,et al.  Does It Really Matter , 2012 .

[148]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[149]  C. Liao,et al.  Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment , 2010, Proceedings of the National Academy of Sciences.

[150]  B. Ramakrishna,et al.  Real‐time polymerase chain reaction quantification of specific butyrate‐producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer , 2008, Journal of gastroenterology and hepatology.

[151]  F. Schmidt Meta-Analysis , 2008 .

[152]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[153]  M. Diamond Facts and fiction. , 1994, Journal of the American Dental Association.

[154]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.